Form 8-K - Current report:
SEC Accession No. 0000950170-25-046085
Filing Date
2025-03-27
Accepted
2025-03-27 16:15:22
Documents
58
Period of Report
2025-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clsd-20250327.htm   iXBRL 8-K 50433
2 EX-99.1 clsd-ex99_1.htm EX-99.1 162983
3 EX-99.2 clsd-ex99_2.htm EX-99.2 45529
4 GRAPHIC img171462827_0.jpg GRAPHIC 23830
5 GRAPHIC clsd-ex99_2s1.jpg GRAPHIC 423878
6 GRAPHIC clsd-ex99_2s2.jpg GRAPHIC 821983
7 GRAPHIC clsd-ex99_2s3.jpg GRAPHIC 317620
8 GRAPHIC clsd-ex99_2s4.jpg GRAPHIC 520027
9 GRAPHIC clsd-ex99_2s5.jpg GRAPHIC 388324
10 GRAPHIC clsd-ex99_2s6.jpg GRAPHIC 341661
11 GRAPHIC clsd-ex99_2s7.jpg GRAPHIC 282235
12 GRAPHIC clsd-ex99_2s8.jpg GRAPHIC 379106
13 GRAPHIC clsd-ex99_2s9.jpg GRAPHIC 252853
14 GRAPHIC clsd-ex99_2s10.jpg GRAPHIC 299340
15 GRAPHIC clsd-ex99_2s11.jpg GRAPHIC 348371
16 GRAPHIC clsd-ex99_2s12.jpg GRAPHIC 323139
17 GRAPHIC clsd-ex99_2s13.jpg GRAPHIC 358249
18 GRAPHIC clsd-ex99_2s14.jpg GRAPHIC 394379
19 GRAPHIC clsd-ex99_2s15.jpg GRAPHIC 250872
20 GRAPHIC clsd-ex99_2s16.jpg GRAPHIC 509553
21 GRAPHIC clsd-ex99_2s17.jpg GRAPHIC 458372
22 GRAPHIC clsd-ex99_2s18.jpg GRAPHIC 131528
23 GRAPHIC clsd-ex99_2s19.jpg GRAPHIC 353792
24 GRAPHIC clsd-ex99_2s20.jpg GRAPHIC 362828
25 GRAPHIC clsd-ex99_2s21.jpg GRAPHIC 266979
26 GRAPHIC clsd-ex99_2s22.jpg GRAPHIC 250786
27 GRAPHIC clsd-ex99_2s23.jpg GRAPHIC 293609
28 GRAPHIC clsd-ex99_2s24.jpg GRAPHIC 336797
29 GRAPHIC clsd-ex99_2s25.jpg GRAPHIC 341514
30 GRAPHIC clsd-ex99_2s26.jpg GRAPHIC 270870
31 GRAPHIC clsd-ex99_2s27.jpg GRAPHIC 388466
32 GRAPHIC clsd-ex99_2s28.jpg GRAPHIC 272083
33 GRAPHIC clsd-ex99_2s29.jpg GRAPHIC 469294
34 GRAPHIC clsd-ex99_2s30.jpg GRAPHIC 433364
35 GRAPHIC clsd-ex99_2s31.jpg GRAPHIC 434501
36 GRAPHIC clsd-ex99_2s32.jpg GRAPHIC 388709
37 GRAPHIC clsd-ex99_2s33.jpg GRAPHIC 404400
38 GRAPHIC clsd-ex99_2s34.jpg GRAPHIC 328934
39 GRAPHIC clsd-ex99_2s35.jpg GRAPHIC 381857
40 GRAPHIC clsd-ex99_2s36.jpg GRAPHIC 509258
41 GRAPHIC clsd-ex99_2s37.jpg GRAPHIC 380013
42 GRAPHIC clsd-ex99_2s38.jpg GRAPHIC 340684
43 GRAPHIC clsd-ex99_2s39.jpg GRAPHIC 340434
44 GRAPHIC clsd-ex99_2s40.jpg GRAPHIC 274154
45 GRAPHIC clsd-ex99_2s41.jpg GRAPHIC 348662
46 GRAPHIC clsd-ex99_2s42.jpg GRAPHIC 330758
47 GRAPHIC clsd-ex99_2s43.jpg GRAPHIC 377524
48 GRAPHIC clsd-ex99_2s44.jpg GRAPHIC 377961
  Complete submission text file 0000950170-25-046085.txt   22549477

Data Files

Seq Description Document Type Size
49 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT clsd-20250327.xsd EX-101.SCH 24862
60 EXTRACTED XBRL INSTANCE DOCUMENT clsd-20250327_htm.xml XML 4719
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 25779491
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)